Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: After-Hours Movers » 18:19
04/13/21
04/13
18:19
04/13/21
18:19
SAP

SAP

$134.51 /

+2.08 (+1.57%)

, FLXN

Flexion

$9.37 /

+1.05 (+12.62%)

, BRKR

Bruker

$68.97 /

+1.43 (+2.12%)

, TEAM

Atlassian

$242.24 /

+11.72 (+5.08%)

, PKI

PerkinElmer

$135.39 /

+2.695 (+2.03%)

, MRNA

Moderna

$149.63 /

+10.34 (+7.42%)

, SEAC

SeaChange

$1.38 /

-0.095 (-6.46%)

, SFIX

Stitch Fix

$49.46 /

-1.3 (-2.56%)

, STSA

Satsuma Pharmaceuticals

$5.44 /

+0.37 (+7.30%)

Check out this evening's…

ShowHide Related Items >><<
TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

STSA Satsuma Pharmaceuticals
$5.44 /

+0.37 (+7.30%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

FLXN Flexion
$9.37 /

+1.05 (+12.62%)

BRKR Bruker
$68.97 /

+1.43 (+2.12%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

04/09/21 Societe Generale
SAP price target lowered to EUR 136 from EUR 138 at Societe Generale
03/25/21 Credit Suisse
SAP assumed with an Outperform at Credit Suisse
03/12/21 JMP Securities
Domo price target raised to $89 from $80 at JMP Securities
03/10/21 Craig-Hallum
Talend go-shop 'could spark interest,' says Craig-Hallum
FLXN Flexion
$9.37 /

+1.05 (+12.62%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
BRKR Bruker
$68.97 /

+1.43 (+2.12%)

02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
02/05/21 Wells Fargo
Bruker downgraded to Equal Weight with $55 target at Wells Fargo
02/05/21 Wells Fargo
Bruker downgraded to Equal Weight from Overweight at Wells Fargo
TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

03/08/21 Morgan Stanley
Software industry rating raised to Attractive from In-Line at Morgan Stanley
03/03/21 Citi
Atlassian assumed with a Buy at Citi
01/29/21 DA Davidson
Atlassian price target raised to $275 from $235 at DA Davidson
01/29/21 BMO Capital
Atlassian price target raised to $260 from $235 at BMO Capital
PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

09/09/20 Lake Street
SeaChange price target lowered to $2 from $4 at Lake Street
SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

04/05/21 Evercore ISI
Stitch Fix initiated with an Outperform at Evercore ISI
03/09/21
Fly Intel: Top five analyst downgrades
03/09/21 Canaccord
Stitch Fix price target lowered to $68 from $72 at Canaccord
03/09/21 KeyBanc
Stitch Fix price target lowered to $75 from $95 at KeyBanc
STSA Satsuma Pharmaceuticals
$5.44 /

+0.37 (+7.30%)

04/05/21 Mizuho
Satsuma Pharmaceuticals price target raised to $7 from $3.50 at Mizuho
03/02/21 Credit Suisse
Satsuma Pharmaceuticals upgraded to Neutral from Underperform at Credit Suisse
03/02/21 Credit Suisse
Satsuma upgraded to Neutral from Underperform at Credit Suisse
11/11/20 Mizuho
Satsuma Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho
TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

STSA Satsuma Pharmaceuticals
$5.44 /

+0.37 (+7.30%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

FLXN Flexion
$9.37 /

+1.05 (+12.62%)

BRKR Bruker
$68.97 /

+1.43 (+2.12%)

  • 30
    Mar
  • 21
    Oct
  • 21
    May
  • 19
    May
SAP SAP
$134.51 /

+2.08 (+1.57%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

BRKR Bruker
$68.97 /

+1.43 (+2.12%)

TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

STSA Satsuma Pharmaceuticals
$5.44 /

+0.37 (+7.30%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

Hot Stocks
Moderna jumps over 2% above $153 after update on COVID-19 variant vaccine  16:37
04/13/21
04/13
16:37
04/13/21
16:37
MRNA

Moderna

$149.63 /

+10.34 (+7.42%)

 
ShowHide Related Items >><<
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

  • 19
    May
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

Hot Stocks
New results from Moderna's COVID-19 variant-specific vaccine show titer increase » 16:33
04/13/21
04/13
16:33
04/13/21
16:33
MRNA

Moderna

$149.63 /

+10.34 (+7.42%)

The company states:…

The company states: "Moderna announced clinical and supply updates on its COVID-19 Vaccine program. New results from a preclinical study of the company's COVID-19 variant-specific vaccine candidates showed that the company's variant-specific booster vaccine candidates - mRNA-1273.351 and mRNA-1273.211 - increase neutralizing titers against SARS-CoV-2 variants of concern. Both mRNA-1273.351 and mRNA-1273.211 increase neutralizing titers against SARS-CoV-2 variants of concern in Balb/c mice. Specifically, this preclinical data confirms improved neutralizing titers with the mRNA-1273.351 vaccine primary series. The multi-valent vaccine provided the broadest level of immunity. A boost at 6 months with mRNA-1273.351 closed the neutralizing titer gap for the variants of concern. Following the mRNA-1273.351 boost, neutralizing titers were comparable between the ancestral strain and the new B.1.351 variant. The company's Phase 2 study to evaluate three approaches to boosting is ongoing.

ShowHide Related Items >><<
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

  • 19
    May
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:27
04/13/21
04/13
16:27
04/13/21
16:27
JNJ

Johnson & Johnson

$159.51 /

-2.075 (-1.28%)

, MRNA

Moderna

$149.63 /

+10.34 (+7.42%)

, COIN

Coinbase

/

+

, AGC

Altimeter Growth

$15.26 /

+1.34 (+9.63%)

, KURI

Alkuri Global Acquisition

$10.01 /

+0.12 (+1.21%)

, BA

Boeing

$253.15 /

+3.49 (+1.40%)

, NVCR

Novocure

$197.33 /

+65.72 (+49.94%)

, AHCO

AdaptHealth

$29.89 /

-7.16 (-19.33%)

, BALY

Bally's

$54.30 /

-6.5 (-10.69%)

, JKPTF

Gamesys Group

$27.00 /

+ (+0.00%)

, ZLAB

Zai Lab

$161.30 /

+29.35 (+22.24%)

The major averages had a…

ShowHide Related Items >><<
ZLAB Zai Lab
$161.30 /

+29.35 (+22.24%)

NVCR Novocure
$197.33 /

+65.72 (+49.94%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
/

+

BALY Bally's
$54.30 /

-6.5 (-10.69%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AHCO AdaptHealth
$29.89 /

-7.16 (-19.33%)

AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
COIN Coinbase
/

+

04/13/21
Fly Intel: Top five analyst initiations
04/13/21 MoffettNathanson
Coinbase initiated with a Buy at MoffettNathanson
04/07/21 JMP Securities
Coinbase report shows 'substantial business momentum,' says JMP Securities
03/03/21
Fly Intel: Top five analyst initiations
AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

KURI Alkuri Global Acquisition
$10.01 /

+0.12 (+1.21%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
03/19/21 Susquehanna
Boeing price target raised to $300 from $250 at Susquehanna
03/15/21 Morgan Stanley
Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
NVCR Novocure
$197.33 /

+65.72 (+49.94%)

04/13/21 Goldman Sachs
Zai Lab price target raised to $211.23 after LUNAR trial update at Goldman Sachs
04/13/21 Wells Fargo
Novocure price target raised to $215 from $135 at Wells Fargo
04/13/21 Guggenheim
Zai Lab price target raised to $250 from $165 at Guggenheim
04/13/21 Piper Sandler
DMC review 'clear positive' for Novocure, says Piper Sandler
AHCO AdaptHealth
$29.89 /

-7.16 (-19.33%)

04/13/21 RBC Capital
AdaptHealth key leadership remains in place, says RBC Capital
04/13/21 Baird
AdaptHealth downgraded to Neutral from Outperform at Baird
04/13/21 Canaccord
Charges against McGee not related to AdaptHealth, says Canaccord
04/13/21 Stifel
Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook
BALY Bally's
$54.30 /

-6.5 (-10.69%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

03/16/21 Jefferies
Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
03/10/21 Berenberg
Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg
03/10/21 Deutsche Bank
Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank
ZLAB Zai Lab
$161.30 /

+29.35 (+22.24%)

02/08/21 Jefferies
Zai Lab price target raised to $225 upon assumption at Jefferies
01/15/21 Citi
Citi boosts Zai Lab target to $216, adds to U.S. Focus List
ZLAB Zai Lab
$161.30 /

+29.35 (+22.24%)

NVCR Novocure
$197.33 /

+65.72 (+49.94%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

COIN Coinbase
/

+

BALY Bally's
$54.30 /

-6.5 (-10.69%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AHCO AdaptHealth
$29.89 /

-7.16 (-19.33%)

  • 14
    Apr
  • 16
    Apr
  • 06
    Jan
  • 15
    Dec
  • 03
    Sep
  • 01
    Jul
  • 19
    May
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

KURI Alkuri Global Acquisition
$10.01 /

+0.12 (+1.21%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

COIN Coinbase
/

+

BALY Bally's
$54.30 /

-6.5 (-10.69%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
/

+

BALY Bally's
$54.30 /

-6.5 (-10.69%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AHCO AdaptHealth
$29.89 /

-7.16 (-19.33%)

AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

Hot Stocks
Cloudflare announces partnership with Nvidia to 'bring AI to the edge at scale' » 13:04
04/13/21
04/13
13:04
04/13/21
13:04
NET

Cloudflare

$72.38 /

+2.73 (+3.92%)

, NVDA

Nvidia

$619.60 /

+11.37 (+1.87%)

Cloudflare (NET)…

Cloudflare (NET) announced it is partnering with Nvidia (NVDA) to "bring AI to the edge at scale." Cloudflare said: "The combination of NVIDIA accelerated computing technology and Cloudflare's edge network will create a massive platform on which developers can deploy applications that use pre-trained or custom machine learning models in seconds. By leveraging the TensorFlow platform developers can use familiar tools to build and test machine learning models, and then deploy them globally onto Cloudflare's edge network."

ShowHide Related Items >><<
NVDA Nvidia
$619.60 /

+11.37 (+1.87%)

NET Cloudflare
$72.38 /

+2.73 (+3.92%)

NET Cloudflare
$72.38 /

+2.73 (+3.92%)

04/12/21 Mizuho
Cloudflare initiated with a Neutral at Mizuho
03/29/21 Baird
Cloudflare well positioned for the long run, says Baird
03/24/21
Fly Intel: Top five analyst upgrades
03/23/21 Truist
Cloudflare upgraded to Buy after customer checks at Truist
NVDA Nvidia
$619.60 /

+11.37 (+1.87%)

04/13/21 Wells Fargo
Nvidia price target raised to $715 from $625 at Wells Fargo
04/13/21 Cowen
Nvidia price target raised to $675 from $665 at Cowen
04/13/21 Credit Suisse
Nvidia price target raised to $700 from $620 at Credit Suisse
04/13/21 Deutsche Bank
Nvidia price target raised to $575 from $560 at Deutsche Bank
NVDA Nvidia
$619.60 /

+11.37 (+1.87%)

NET Cloudflare
$72.38 /

+2.73 (+3.92%)

NVDA Nvidia
$619.60 /

+11.37 (+1.87%)

NET Cloudflare
$72.38 /

+2.73 (+3.92%)

NVDA Nvidia
$619.60 /

+11.37 (+1.87%)

NET Cloudflare
$72.38 /

+2.73 (+3.92%)

NVDA Nvidia
$619.60 /

+11.37 (+1.87%)

NET Cloudflare
$72.38 /

+2.73 (+3.92%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:06
04/13/21
04/13
12:06
04/13/21
12:06
JNJ

Johnson & Johnson

$157.65 /

-3.935 (-2.44%)

, MRNA

Moderna

$149.34 /

+10.05 (+7.22%)

, GRAB

Grab

/

+

, COIN

Coinbase

$0.00 /

+ (+0.00%)

, BA

Boeing

$251.46 /

+1.8 (+0.72%)

, AGC

Altimeter Growth

$13.46 /

-0.46 (-3.30%)

, NVCR

Novocure

$185.99 /

+54.38 (+41.32%)

, CDLX

Cardlytics

$102.70 /

-9.03 (-8.08%)

, AHCO

AdaptHealth

$31.35 /

-5.7 (-15.38%)

, BALY

Bally's

$54.81 /

-5.99 (-9.85%)

, JKPTF

Gamesys Group

$27.00 /

+ (+0.00%)

The major averages are…

ShowHide Related Items >><<
NVCR Novocure
$185.99 /

+54.38 (+41.32%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$149.34 /

+10.05 (+7.22%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
GRAB Grab
/

+

COIN Coinbase
$0.00 /

+ (+0.00%)

04/13/21
Fly Intel: Top five analyst initiations
04/13/21 MoffettNathanson
Coinbase initiated with a Buy at MoffettNathanson
04/07/21 JMP Securities
Coinbase report shows 'substantial business momentum,' says JMP Securities
03/03/21
Fly Intel: Top five analyst initiations
BA Boeing
$251.46 /

+1.8 (+0.72%)

04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
03/19/21 Susquehanna
Boeing price target raised to $300 from $250 at Susquehanna
03/15/21 Morgan Stanley
Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

NVCR Novocure
$185.99 /

+54.38 (+41.32%)

04/13/21 Wells Fargo
Novocure price target raised to $215 from $135 at Wells Fargo
04/13/21 Guggenheim
Zai Lab price target raised to $250 from $165 at Guggenheim
04/13/21 Piper Sandler
DMC review 'clear positive' for Novocure, says Piper Sandler
03/01/21 Mizuho
Novocure price target raised to $175 from $150 at Mizuho
CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

03/16/21 JPMorgan
Cardlytics price target raised to $130 from $110 at JPMorgan
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

04/13/21 Canaccord
Charges against McGee not related to AdaptHealth, says Canaccord
04/13/21 Stifel
Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook
04/12/21 Baird
AdaptHealth price target raised to $49 from $47 at Baird
03/18/21 Truist
AdaptHealth initiated with a Buy at Truist amid home health market shift
BALY Bally's
$54.81 /

-5.99 (-9.85%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

03/16/21 Jefferies
Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
03/10/21 Berenberg
Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg
03/10/21 Deutsche Bank
Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank
NVCR Novocure
$185.99 /

+54.38 (+41.32%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

COIN Coinbase
$0.00 /

+ (+0.00%)

CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

  • 14
    Apr
  • 16
    Apr
  • 03
    Mar
  • 06
    Jan
  • 15
    Dec
  • 03
    Sep
  • 01
    Jul
  • 19
    May
MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

On The Fly
Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine » 11:12
04/13/21
04/13
11:12
04/13/21
11:12
JNJ

Johnson & Johnson

$157.42 /

-4.165 (-2.58%)

, MRNA

Moderna

$150.11 /

+10.82 (+7.77%)

, PFE

Pfizer

$37.14 /

+0.16 (+0.43%)

Shares of Johnson &…

ShowHide Related Items >><<
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$150.11 /

+10.82 (+7.77%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

  • 19
    May
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

Options
Moderna call volume above normal and directionally bullish » 10:25
04/13/21
04/13
10:25
04/13/21
10:25
MRNA

Moderna

$149.00 /

+9.71 (+6.97%)

Bullish option flow…

Bullish option flow detected in Moderna with 28,974 calls trading, 4x expected, and implied vol increasing over 4 points to 64.56%. Apr-21 150 calls and Apr-21 160 calls are the most active options, with total volume in those strikes near 8,000 contracts. The Put/Call Ratio is 0.33. Earnings are expected on May 5th.

ShowHide Related Items >><<
MRNA Moderna
$149.00 /

+9.71 (+6.97%)

MRNA Moderna
$149.00 /

+9.71 (+6.97%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
MRNA Moderna
$149.00 /

+9.71 (+6.97%)

  • 19
    May
MRNA Moderna
$149.00 /

+9.71 (+6.97%)

MRNA Moderna
$149.00 /

+9.71 (+6.97%)

MRNA Moderna
$149.00 /

+9.71 (+6.97%)

Options
Early notable gainers among liquid option names on April 13th » 09:55
04/13/21
04/13
09:55
04/13/21
09:55
TSLA

Tesla

$721.88 /

+20.69 (+2.95%)

, HOLX

Hologic

$75.72 /

+1.32 (+1.77%)

, NVDA

Nvidia

$618.75 /

+10.52 (+1.73%)

, DHR

Danaher

$239.37 /

+4.49 (+1.91%)

, ETSY

Etsy

$224.50 /

+6.2 (+2.84%)

Notable gainers among…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$721.88 /

+20.69 (+2.95%)

NVDA Nvidia
$618.75 /

+10.52 (+1.73%)

HOLX Hologic
$75.72 /

+1.32 (+1.77%)

ETSY Etsy
$224.50 /

+6.2 (+2.84%)

DHR Danaher
$239.37 /

+4.49 (+1.91%)

TSLA Tesla
$721.88 /

+20.69 (+2.95%)

07:58 Today Credit Suisse
Credit Suisse ahead of consensus into Q1 EPS for Tesla
04/12/21
Fly Intel: Top five analyst upgrades
04/12/21 Canaccord
Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem
04/12/21 Canaccord
Tesla upgraded to Buy from Hold at Canaccord
HOLX Hologic
$75.72 /

+1.32 (+1.77%)

04/05/21 Jefferies
Hologic price target raised to $110 from $106 at Jefferies
02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
NVDA Nvidia
$618.75 /

+10.52 (+1.73%)

08:56 Today Wells Fargo
Nvidia price target raised to $715 from $625 at Wells Fargo
07:49 Today Cowen
Nvidia price target raised to $675 from $665 at Cowen
07:12 Today Credit Suisse
Nvidia price target raised to $700 from $620 at Credit Suisse
07:08 Today Deutsche Bank
Nvidia price target raised to $575 from $560 at Deutsche Bank
DHR Danaher
$239.37 /

+4.49 (+1.91%)

04/08/21 Citi
Citi opens 'positive catalyst watch' on Danaher, sees Q1 beat
04/07/21 Baird
Danaher assumed with an Outperform at Baird
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/02/21 Barclays
Danaher started at Overweight at Barclays on GE biopharma business potential
ETSY Etsy
$224.50 /

+6.2 (+2.84%)

04/05/21 Evercore ISI
Etsy initiated with an Outperform at Evercore ISI
03/29/21 Deutsche Bank
Etsy price target raised to $239 from $162 at Deutsche Bank
03/02/21 Citi
Etsy price target raised to $260 from $250 at Citi
02/26/21 Morgan Stanley
Etsy price target raised to $123 from $93 at Morgan Stanley
TSLA Tesla
$721.88 /

+20.69 (+2.95%)

NVDA Nvidia
$618.75 /

+10.52 (+1.73%)

HOLX Hologic
$75.72 /

+1.32 (+1.77%)

ETSY Etsy
$224.50 /

+6.2 (+2.84%)

DHR Danaher
$239.37 /

+4.49 (+1.91%)

  • 08
    May
TSLA Tesla
$721.88 /

+20.69 (+2.95%)

NVDA Nvidia
$618.75 /

+10.52 (+1.73%)

HOLX Hologic
$75.72 /

+1.32 (+1.77%)

ETSY Etsy
$224.50 /

+6.2 (+2.84%)

DHR Danaher
$239.37 /

+4.49 (+1.91%)

TSLA Tesla
$721.88 /

+20.69 (+2.95%)

NVDA Nvidia
$618.75 /

+10.52 (+1.73%)

HOLX Hologic
$75.72 /

+1.32 (+1.77%)

ETSY Etsy
$224.50 /

+6.2 (+2.84%)

TSLA Tesla
$721.88 /

+20.69 (+2.95%)

NVDA Nvidia
$618.75 /

+10.52 (+1.73%)

HOLX Hologic
$75.72 /

+1.32 (+1.77%)

ETSY Etsy
$224.50 /

+6.2 (+2.84%)

DHR Danaher
$239.37 /

+4.49 (+1.91%)

Hot Stocks
White House says J&J pause will not significantly impact vaccination plan » 09:47
04/13/21
04/13
09:47
04/13/21
09:47
JNJ

Johnson & Johnson

$157.25 /

-4.335 (-2.68%)

, MRNA

Moderna

$147.74 /

+8.45 (+6.07%)

, PFE

Pfizer

$37.35 /

+0.37 (+1.00%)

The White House said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

09:34 Today Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
09:33 Today Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
09:21 Today JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$147.74 /

+8.45 (+6.07%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
PFE Pfizer
$37.35 /

+0.37 (+1.00%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

  • 19
    May
PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

PFE Pfizer
$37.35 /

+0.37 (+1.00%)

MRNA Moderna
$147.74 /

+8.45 (+6.07%)

JNJ Johnson & Johnson
$157.25 /

-4.335 (-2.68%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.